Event category: Concurrent Session

Events

September 05, 2025

2025-09-05

04:45 PM (EDT) - 05:30 PM (EDT)

The Xchange

Concurrent Session

Meet the HRX Live Producers

Suneet Mittal | Jonathan Piccini | Prashanathan Sanders

Suneet Mittal

Chair, Cardiovascular Service Line

Valley Health System

Jonathan Piccini

Cardiac Electrophysiologist & Professor of Medicine and Population Health | Director of the Cardiac Electrophysiology section

Duke University Hospital and the Duke Clinical Research Institute | Duke Heart Center

Prashanthan Sanders

Cardiac Electrophysiologist & Director of Cardiac Electrophysiology

University of Adelaide

2025-09-05

12:30 PM (EDT) - 01:15 PM (EDT)

Innovation Stage

Concurrent Session

Global Pulse: Cardiovascular Innovation Beyond Borders

While much of the conversation around cardiovascular innovation centers on developments in the United States, transformative work is also taking place around the world. In this dynamic session, internationally recognized leaders will spotlight how their institutions and regions are shaping the future of cardiovascular care—from groundbreaking clinical trials and digital health platforms to regulatory strategies, new care delivery models, and cutting-edge procedural innovations.

David Duncker, MD, FHRS

Head of Hannover Heart Rhythm Center

Hannover Medical School

Sabine Ernst

Professor of Practice (Cardiology)

Imperial College London

Gerhard Hindricks, MD, PhD

Medical Director

Charite University Hospital, Berlin

Arun Jose

Deputy Director & Head

BRIDGE Centre for Digital Health, Centre for Chronic Disease Control

Nagesh Rangappan

CEO

PreMedAI Labs P Ltd.

Deepak Padmanabhan

Assistant Professor

Sri Jayadeva Institute of Cardiovascular Sciences and Research

September 06, 2025

2025-09-06

08:00 AM (EDT) - 09:30 AM (EDT)

Main Stage 1

Concurrent Session Pitch Competition

HRX Pitch Competition II

The HRX 2025 Pitch Competition provides cardiovascular startups with a platform to present their innovative products, services, and solutions to a distinguished panel of judges and potential investors and win cash prices. The top five teams selected will compete on the HRX Main Stage. Each team will have ~5-10 minutes to creatively pitch their innovative idea, followed by five minutes to field questions from judges and attendees.

Daniel Gelman

Chief Executive Officer

Aufero Medical

Rodney Horton

Clinical Electrophysiologist

Texas Cardiac Arrhythmia

Kashif Khan

Co-Founder & Chief Scientific Officer

Sonaro

Daniel Lee

Chief Executive Officer

Lumia

Ryan Neely

CEO & Co-Founder | Scientific Advisor

Skribe Medical | Elemind Technologies, Inc.

Tony Fiola

Vice President & General Manager

Global Cardiac Diagnostic Services Franchise at Boston Scientific

Robert Kowal

Vice President and General Manager, Cardiac Pacing Therapies | Cardiac Electrophysiologist

Medtronic

Nishaki Mehta

Associate Professor of Medicine

William Beaumont Oakland University School of Medicine

Ken Nelson

Partner | Board Chairman & Investor | Investor & Mentor

Medtech Advantage Fund | CardiaCare | HeartBeam, BloomLife, & HeartX

Mintu Turakhia

Chief Medical and Scientific Officer + EVP, Product Management and Innovation | Professor of Medicine and Cardiac Electrophysiologist

iRhythm Technologies, Inc. | Stanford University

September 05, 2025

2025-09-05

01:15 PM (EDT) - 02:45 PM (EDT)

Main Stage 1

Concurrent Session Pitch Competition

HRX Pitch Competition I

Kasper Bourdette

Sanna Gaspard

CEO & Founder

Rubitection Inc.

Andreas Pfahnl

Cofounder, President & CEO

Kobara Medical Inc

Eric Sandberg

Chief Business Officer

Inomagen Therapeutics

Vidur Sahney

Tony Fiola

Vice President & General Manager

Global Cardiac Diagnostic Services Franchise at Boston Scientific

Robert Kowal

Vice President and General Manager, Cardiac Pacing Therapies | Cardiac Electrophysiologist

Medtronic

Nishaki Mehta

Associate Professor of Medicine

William Beaumont Oakland University School of Medicine

Ken Nelson

Partner | Board Chairman & Investor | Investor & Mentor

Medtech Advantage Fund | CardiaCare | HeartBeam, BloomLife, & HeartX

Mintu Turakhia

Chief Medical and Scientific Officer + EVP, Product Management and Innovation | Professor of Medicine and Cardiac Electrophysiologist

iRhythm Technologies, Inc. | Stanford University

2025-09-05

02:00 PM (EDT) - 02:45 PM (EDT)

Innovation Stage

Concurrent Session

Innovation in Lead Extraction: Moving Beyond the Tools of Today

Lead extraction is an important treatment option for many patients with cardiac implanted electronic devices. While outcomes with lead extraction have improved over time, the tools used for lead extraction have remained relatively unchanged over the past 10+ years. There are now a variety of technologies in development that approach lead extraction through a fundamentally different approach. This discussion will focus on the unmet needs in lead management and how new developments and technologies may improve extraction procedures, subsequent outcomes, and perhaps even patient access.

George Crossley

Professor of Medicine in the Division of Cardiovascular Medicine

Vanderbilt University Medical Center

Anne Kroman

Associate Professor of Cardiac Electrophysiology | Director of the Lead Management Program, the Cardiac Device Clinic, and MUSC Heart Station

Medical University of South Carolina

Weston Lee

Senior R&D Manager

Philips

Faisal Merchant

Director of Cardiac Electrophysiology and Associate Professor of Medicine

Emory Healthcare

Emily Zeitler, MD, MHS

Associate Professor of Medicine

Geisel School of Medicine and The Dartmouth Institute

Jonathan Piccini

Cardiac Electrophysiologist & Professor of Medicine and Population Health | Director of the Cardiac Electrophysiology section

Duke University Hospital and the Duke Clinical Research Institute | Duke Heart Center

September 04, 2025

2025-09-04

02:45 PM (EDT) - 03:30 PM (EDT)

Innovation Stage

Concurrent Session

Integrating ASCs into Practice and Innovation

Electrophysiologic procedural care has been largely relegated to hospitals for decades. The looming approval of ablation procedures in ambulatory surgical centers has the potential to bring a sea change to the EP field. This session will explore how ASCs may help innovate EP care delivery models. The session will also discuss how ASCs will disrupt current practice patterns, create selective pressures in different practice models, and change many aspects of research and quality improvement across EP.

Chad Bonhomme

President & Electrophysiologist

Westfield Physician Holdings, LLC

Gopi Dandamudi

Founding President

Heart & Vascular Institute at Prisma Health

Dhanunjaya R. Lakkireddy

Executive Medical Director of the Kansas City Heart Rhythm Institute

HCA Midwest in Overland Park, Kansas

Usman Siddiqui

Electrophysiologist

Florida Cardiology

Kamala Tamirisa

Clinical Cardiac Electrophysiologist & Cardiac MR Imaging Specialist

Texas Cardiac Arrhythmia

Arash Aryana

Cardiac Electrophysiologist & Medical Director

Mercy General Hospital

September 05, 2025

2025-09-05

09:45 AM (EDT) - 10:30 AM (EDT)

Innovation Stage

Concurrent Session

FHIR-Forward: The Role of HL7 FHIR Accelerators in Electrophysiology

The success of interoperability standards for cardiac implantable electronic devices (CIEDs), driven by IEEE 11073 and HL7’s CardX FHIR accelerator, is paving the way for a broader transformation in cardiovascular data exchange. This session will explore how FHIR-based frameworks are being applied to real-world CIED use cases, and how these lessons can now be extended to wearable monitors, arrhythmia detection platforms, and beyond.
Panelists will share their experiences shaping the evolving ecosystem—from technical implementation to clinical impact—and discuss the opportunities and challenges of scaling this work across cardiology. Special focus will be given to AI-readiness, the need for semantic consistency, and the role of industry and regulatory stakeholders in driving adoption.

Chris Irving

Co-Founder, Chief Experience Officer & Head of Design

Murj Inc.

George Stuart Mendenhall

Cardiac Electrophysiologist and Researcher | Chief Medical Officer

Scripps Memorial Hospital | Everbeat

Andy Iverson

Senior Principal Software Engineer

Medtronic

Craig Reister

Systems Engineer

Boston Scientific

Paul Steiner

Electrophysiologist

Dartmouth Hitchcock Medical Center

John Windle

Professor

University of Nebraska Medical Center

David Slotwiner

Chief of the Division of Cardiology

New York Presbyterian Queens

September 04, 2025

2025-09-04

02:45 PM (EDT) - 03:30 PM (EDT)

Main Stage 1

Concurrent Session

Accelerating Innovations Early in the Chain of Survival after Sudden Cardiac Arrest

SCA is a persistent public health problem, but little has changed over the past several decades. This session will highlight new approaches to the prevention and treatment of SCA that leverage innovative technologies and systems of care. Special attention will be given to how different technologies, education, and predictive analytics can synergize to improve the problem of SCA and improve outcomes.

Alan Cheng

Chief Medical Officer of the Medtronic Cardiac Rhythm Management Operating Unit

Medtronic

Sumeet Chugh

Price Endowed Professor & Associate Director, Heart Institute | Director Artificial Intelligence in Medicine

Cedars-Sinai Health System

April Heinze

Vice President and Chief of 9-1-1 Operations

NENA: The 9-1-1 Association

Richard Price

Founder & President

PulsePoint Foundation

Jake Sunshine

Associate Professor | Research Scientist | Past Founder and Chief Medical Officer

UW School of Medicine | Google | Sound Life Sciences (acquired by Google)

Natalia Trayanova, PhD, FHRS

Professor | Director for AI Research

Johns Hopkins University

Paul Wang

Director of the Stanford Cardiac Arrhythmia Service & Professor of Medicine and of Bioengineering

Stanford Medicine

Mina K. Chung

Staff Cardiologist & Professor of Medicine in the Section of Pacing and Electrophysiology

Cleveland Clinic

September 05, 2025

2025-09-05

01:15 PM (EDT) - 02:00 PM (EDT)

Main Stage 2

Concurrent Session

Early Feasibility Studies and EP Innovation

EP Collaboratory to share efforts between industry and early stage companies to promote EFS within the US to increase patient access to new technologies and to support device innovation.

Julia Berzhanskaya

Program Director for trans-NIH REACH 2.0 and Innovator Support Lead

National Heart Lung and Blood Institute (NHLBI) Innovation& Commercialization Office

Andrea Russo, MD

Academic Chief, Division of Cardiology | Director, Cardiac Electrophysiology and Arrhythmia Services | Director, CCEP Fellowship

Cooper University Hospital

J. Peter Weiss

Cardiac Electrophysiologist

Banner University of Arizona Medical Center Phoenix (BUMCP)

Khaldoun Tarakji

Chief Medical Officer and Vice President, Clinical Research and Medical Science for Cardiac Ablation Solutions

Medtronic

Liat Tsoref

Senior Director of Digital, AI and Customer Collaboration

Biosense Webster

Paul Wang

Director of the Stanford Cardiac Arrhythmia Service & Professor of Medicine and of Bioengineering

Stanford Medicine

2025-09-05

03:00 PM (EDT) - 03:45 PM (EDT)

Main Stage 1

Concurrent Session

Pulsed Field Ablation: The End of the Beginning

By the time of HRX 2025, pulsed field ablation will have been clinically available in the US for more than a year and a half. While first-gen systems have brought notable changes to EP, these first-generation systems only represent the very beginning of PFA. This session will focus on discussion of the key developments and advances for next generation PFA technologies, including advances in pulse sequences, catheter design, integration with electroanatomic mapping, and patient- and anatomic-specific custom lesion formation.